Aratana Therapeutics Inc (NASDAQ:PETX)

19.23
Delayed Data
As of Feb 26
 +0.47 / +2.51%
Today’s Change
9.20
Today|||52-Week Range
23.88
+7.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

--
Revenue and IncomeNet Revenues0.000.00123.0K--
 
 
Cost of Goods Sold0.000.0092.0K--
 
 
Depreciation And Amortization4.0K13.0K396.0K--
 
 
 
 
 
Operating ExpensesGross Income-4.0K-13.0K-365.0K--
 
 
 
 
General Expenses3.5M10.3M17.8M--
 
 
 
 
Research And Development2.2M7.3M10.9M--
 
 
 
 
Total Operating Expenses3.5M10.3M18.3M--
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.5M-10.3M-18.2M--
 
 
 
 
Extraordinary Charge0.00-1.5M-1.7M--
 
 
 
Interest Expense On Debt0.000.00432.0K--
 
 
Other Expenses0.00121.0K477.0K--
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.5M-11.6M-19.7M--
 
 
 
 
Income Taxes0.000.00-15.5M--
 
 
Net Income-3.5M-11.6M-4.3M--
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.5M11.5M11.1M--
 
 
 
 
Shares To Calculate EPS Diluted11.5M11.5M11.1M--
 
 
 
 
 
Earnings Per ShareEPS-$15.43-$1.01-$0.39--
 
 
 
 
EPS Diluted-$0.30-$1.01-$0.39--
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account